Basic Information
| RNALocate ID: | RLID:11002494 |
| RNA Symbol: | hsa-miR-374a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-374a-5p |
| RNA ID: | miRBase:MIMAT0000727 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24683445 |
| Tissue/Cell Line: | Plasma|Serum |
| Method: | Next-generation RNA sequencing |
| Description: | Exosomes are enriched with miRNA: Small RNA libraries of the samples described above were constructed for small RNA-seq by NGS. The number of miRNA identified in this study was 943 of 2,233 known mature miRNA from miRBase V.20. Mapping to Ensembl Release 74 was performed to identify other non-coding RNA such as tRNA, rRNA, small nucleolar RNA (snoRNA) and LincRNA. The average across all 3 samples was calculated to obtain a representative profile of biological diversity between patients (standard deviations of reads in Supplementary file). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002032 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002033 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002034 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002035 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:01002036 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11002489 | Exosome | Serum | 18589210 |
| RLID:11002490 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002491 | Exosome | Brain tissue | 23382797 |
| RLID:11002492 | Exosome | Plasma | 23663360 |
| RLID:11002493 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002495 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000120 | Exosome | Seminal fluid | |
| RLID-D:11000415 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-374a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-45519 |
| MNDR | hsa-miR-374a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-45520 |
| MNDR | hsa-miR-374a-5p | Oral squamous cell carcinoma | MNDR-E-MI-45521 |
| MNDR | hsa-miR-374a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-45522 |
| MNDR | hsa-miR-374a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-45523 |
| MNDR | hsa-miR-374a-5p | Lymphoma | MNDR-E-MI-45524 |
| MNDR | hsa-miR-374a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-45525 |
| MNDR | hsa-miR-374a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-45526 |
| MNDR | hsa-miR-374a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-45527 |
| MNDR | hsa-miR-374a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-45528 |
| MNDR | hsa-miR-374a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-45529 |
| MNDR | hsa-miR-374a-5p | Breast cancer luminal | MNDR-E-MI-45530 |
| MNDR | hsa-miR-374a-5p | Niemann-pick disease type c | MNDR-E-MI-45531 |
| MNDR | hsa-miR-374a-5p | Prostate cancer | MNDR-E-MI-45532 |
| MNDR | hsa-miR-374a-5p | Gastric cancer | MNDR-E-MI-45533 |
| MNDR | hsa-miR-374a-5p | Gastric lymphoma | MNDR-E-MI-45534 |
| MNDR | hsa-miR-374a-5p | Alzheimer disease | MNDR-E-MI-45535 |
| MNDR | hsa-miR-374a-5p | Intracranial aneurysm | MNDR-E-MI-45536 |
| MNDR | hsa-miR-374a-5p | Esophageal carcinoma | MNDR-E-MI-45537 |
| MNDR | hsa-miR-374a-5p | Dysautonomia familial | MNDR-E-MI-45538 |
| MNDR | hsa-miR-374a-5p | Cardiovascular disease | MNDR-E-MI-45539 |
| MNDR | hsa-miR-374a-5p | Parkinson disease | MNDR-E-MI-45540 |
| MNDR | hsa-miR-374a-5p | Machado-joseph disease | MNDR-E-MI-45541 |
| MNDR | hsa-miR-374a-5p | Niemann-pick disease | MNDR-E-MI-45542 |
| MNDR | hsa-miR-374a-5p | Basal-like breast cancer | MNDR-E-MI-45543 |
| MNDR | hsa-miR-374a-5p | Pancreatic cancer | MNDR-E-MI-45544 |
| MNDR | hsa-miR-374a-5p | Melanoma | MNDR-E-MI-45545 |
| MNDR | hsa-miR-374a-5p | Rectum adenocarcinoma | MNDR-E-MI-45546 |
| MNDR | hsa-miR-374a-5p | Nephroblastoma | MNDR-E-MI-45547 |
| MNDR | hsa-miR-374a-5p | Colon cancer | MNDR-E-MI-45548 |
| MNDR | hsa-miR-374a-5p | Hypoxia-ischemia brain | MNDR-E-MI-45549 |
| MNDR | hsa-miR-374a-5p | Colon adenocarcinoma | MNDR-E-MI-45550 |
| MNDR | hsa-miR-374a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-45551 |
| MNDR | hsa-miR-374a-5p | Prostate adenocarcinoma | MNDR-E-MI-45552 |
| MNDR | hsa-miR-374a-5p | Glioblastoma | MNDR-E-MI-45553 |
| MNDR | hsa-miR-374a-5p | Glioma | MNDR-E-MI-45554 |
| MNDR | hsa-miR-374a-5p | Oligodendroglioma | MNDR-E-MI-45555 |
| MNDR | hsa-miR-374a-5p | Epilepsy temporal lobe | MNDR-E-MI-45556 |
| MNDR | hsa-miR-374a-5p | Osteosarcoma | MNDR-E-MI-45557 |
| MNDR | hsa-miR-374a-5p | Liposarcoma | MNDR-E-MI-45558 |
| MNDR | hsa-miR-374a-5p | Meningioma | MNDR-E-MI-45559 |
| MNDR | hsa-miR-374a-5p | Gastric adenocarcinoma | MNDR-E-MI-45560 |
| MNDR | hsa-miR-374a-5p | Lung squamous cell carcinoma | MNDR-E-MI-45561 |
| MNDR | hsa-miR-374a-5p | Lung adenocarcinoma | MNDR-E-MI-45562 |
| MNDR | hsa-miR-374a-5p | Adrenocortical cancer | MNDR-E-MI-45563 |
| MNDR | hsa-miR-374a-5p | Thyroid carcinoma | MNDR-E-MI-45564 |
| MNDR | hsa-miR-374a-5p | Bladder urothelial carcinoma | MNDR-E-MI-45565 |
| MNDR | hsa-miR-374a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-45566 |
| MNDR | hsa-miR-374a-5p | Carcinoma renal cell | MNDR-E-MI-45567 |
| MNDR | hsa-miR-374a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-45568 |
| MNDR | hsa-miR-374a-5p | Renal clear cell carcinoma | MNDR-E-MI-45569 |
| MNDR | hsa-miR-374a-5p | Cholangiocarcinoma | MNDR-E-MI-45570 |
| MNDR | hsa-miR-374a-5p | Synovial sarcoma | MNDR-E-MI-45571 |
| MNDR | hsa-miR-374a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-45572 |
| MNDR | hsa-miR-374a-5p | Early hepatocellular carcinoma | MNDR-E-MI-45573 |
| MNDR | hsa-miR-374a-5p | Embryonal cancer | MNDR-E-MI-45574 |
| MNDR | hsa-miR-374a-5p | B-cell lymphoma | MNDR-E-MI-45575 |
| MNDR | hsa-miR-374a-5p | Rheumatoid arthritis | MNDR-E-MI-45576 |
| MNDR | hsa-miR-374a-5p | T-cell leukemia | MNDR-E-MI-45577 |
| MNDR | hsa-miR-374a-5p | Retinoblastoma | MNDR-E-MI-45578 |
| MNDR | hsa-miR-374a-5p | Barrett's adenocarcinoma | MNDR-E-MI-45579 |
| MNDR | hsa-miR-374a-5p | Hodgkin lymphoma | MNDR-E-MI-45580 |
| MNDR | hsa-miR-374a-5p | Burkitt lymphoma | MNDR-E-MI-45581 |
| MNDR | hsa-miR-374a-5p | Psoriasis | MNDR-E-MI-45582 |
| MNDR | hsa-miR-374a-5p | Acute myelocytic leukemia | MNDR-E-MI-45583 |
| MNDR | hsa-miR-374a-5p | Colorectal cancer | MNDR-E-MI-45584 |
| MNDR | hsa-miR-374a-5p | Nasopharynx carcinoma | MNDR-E-MI-45585 |
| MNDR | hsa-miR-374a-5p | Multiple myeloma | MNDR-E-MI-45586 |
| MNDR | hsa-miR-374a-5p | Ovarian epithelial cancer | MNDR-E-MI-45587 |
| MNDR | hsa-miR-374a-5p | Nasopharyngeal cancer | MNDR-E-MI-45588 |
| MNDR | hsa-miR-374a-5p | Epstein-barr virus infections | MNDR-E-MI-45589 |
| MNDR | hsa-miR-374a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-45590 |
| MNDR | hsa-miR-374a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-45591 |
| MNDR | hsa-miR-374a-5p | Stroke lacunar | MNDR-E-MI-45592 |
| MNDR | hsa-miR-374a-5p | Barrett's carcinogenesis | MNDR-E-MI-45593 |
| MNDR | hsa-miR-374a-5p | High grade dysplastic nodule | MNDR-E-MI-45594 |
| MNDR | hsa-miR-374a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-45595 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ATM | Homo sapiens | RR00158102 |
TOP